ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/07/18 | 1,505 | 1,522 | 1,441 | 1,466 | -9 | -0.6% | 1,596,000 |
2018/07/17 | 1,600 | 1,611 | 1,475 | 1,475 | -147 | -9.1% | 2,107,800 |
2018/07/13 | 1,720 | 1,767 | 1,604 | 1,622 | -73 | -4.3% | 3,036,600 |
2018/07/12 | 1,657 | 1,814 | 1,640 | 1,695 | +99 | +6.2% | 7,083,900 |
2018/07/11 | 1,585 | 1,659 | 1,552 | 1,596 | +1 | +0.1% | 2,594,800 |
2018/07/10 | 1,585 | 1,687 | 1,545 | 1,595 | -30 | -1.8% | 5,707,300 |
2018/07/09 | 1,619 | 1,660 | 1,520 | 1,625 | +265 | +19.5% | 7,579,000 |
2018/07/06 | 1,360 | 1,360 | 1,330 | 1,360 | +300 | +28.3% | 869,500 |
2018/07/05 | 1,152 | 1,164 | 1,046 | 1,060 | -92 | -8% | 1,675,400 |
2018/07/04 | 1,240 | 1,255 | 1,148 | 1,152 | -79 | -6.4% | 1,326,300 |
2018/07/03 | 1,284 | 1,353 | 1,215 | 1,231 | -68 | -5.2% | 889,000 |
2018/07/02 | 1,342 | 1,355 | 1,290 | 1,299 | -54 | -4% | 441,000 |
2018/06/29 | 1,283 | 1,353 | 1,270 | 1,353 | +81 | +6.4% | 538,900 |
2018/06/28 | 1,294 | 1,317 | 1,267 | 1,272 | -32 | -2.5% | 424,100 |
2018/06/27 | 1,300 | 1,328 | 1,286 | 1,304 | -11 | -0.8% | 304,400 |
2018/06/26 | 1,288 | 1,326 | 1,251 | 1,315 | +7 | +0.5% | 385,000 |
2018/06/25 | 1,385 | 1,396 | 1,290 | 1,308 | -61 | -4.5% | 507,800 |
2018/06/22 | 1,367 | 1,387 | 1,342 | 1,369 | -31 | -2.2% | 378,000 |
2018/06/21 | 1,400 | 1,443 | 1,359 | 1,400 | +24 | +1.7% | 879,100 |
2018/06/20 | 1,314 | 1,385 | 1,304 | 1,376 | +48 | +3.6% | 925,500 |
2018/06/19 | 1,442 | 1,445 | 1,325 | 1,328 | -124 | -8.5% | 1,494,000 |
2018/06/18 | 1,484 | 1,521 | 1,428 | 1,452 | -133 | -8.4% | 1,327,400 |
2018/06/15 | 1,605 | 1,645 | 1,567 | 1,585 | -47 | -2.9% | 1,067,200 |
2018/06/14 | 1,588 | 1,682 | 1,561 | 1,632 | +20 | +1.2% | 3,163,200 |
2018/06/13 | 1,520 | 1,653 | 1,519 | 1,612 | +165 | +11.4% | 6,141,800 |
2018/06/12 | 1,426 | 1,466 | 1,400 | 1,447 | +10 | +0.7% | 1,138,600 |
2018/06/11 | 1,481 | 1,492 | 1,391 | 1,437 | -55 | -3.7% | 2,384,500 |
2018/06/08 | 1,275 | 1,560 | 1,266 | 1,492 | +232 | +18.4% | 8,196,600 |
2018/06/07 | 1,215 | 1,283 | 1,203 | 1,260 | +72 | +6.1% | 1,056,900 |
2018/06/06 | 1,222 | 1,234 | 1,172 | 1,188 | -28 | -2.3% | 934,600 |
2018/06/05 | 1,235 | 1,272 | 1,210 | 1,216 | -24 | -1.9% | 872,200 |
2018/06/04 | 1,330 | 1,330 | 1,223 | 1,240 | -80 | -6.1% | 1,297,900 |
2018/06/01 | 1,343 | 1,373 | 1,308 | 1,320 | -40 | -2.9% | 719,500 |
2018/05/31 | 1,310 | 1,403 | 1,308 | 1,360 | +54 | +4.1% | 1,409,600 |
2018/05/30 | 1,342 | 1,357 | 1,302 | 1,306 | -77 | -5.6% | 795,400 |
2018/05/29 | 1,388 | 1,389 | 1,313 | 1,383 | +41 | +3.1% | 967,600 |
2018/05/28 | 1,350 | 1,384 | 1,326 | 1,342 | -2 | -0.1% | 680,800 |
2018/05/25 | 1,340 | 1,400 | 1,328 | 1,344 | -8 | -0.6% | 924,100 |
2018/05/24 | 1,424 | 1,436 | 1,348 | 1,352 | -65 | -4.6% | 1,237,000 |
2018/05/23 | 1,443 | 1,481 | 1,414 | 1,417 | -43 | -2.9% | 808,300 |
2018/05/22 | 1,455 | 1,540 | 1,426 | 1,460 | +10 | +0.7% | 1,386,100 |
2018/05/21 | 1,431 | 1,485 | 1,430 | 1,450 | +2 | +0.1% | 534,100 |
2018/05/18 | 1,430 | 1,456 | 1,401 | 1,448 | -12 | -0.8% | 851,600 |
2018/05/17 | 1,430 | 1,477 | 1,418 | 1,460 | +15 | +1% | 525,600 |
2018/05/16 | 1,514 | 1,521 | 1,437 | 1,445 | -85 | -5.6% | 1,034,300 |
2018/05/15 | 1,629 | 1,639 | 1,519 | 1,530 | -69 | -4.3% | 940,300 |
2018/05/14 | 1,550 | 1,685 | 1,535 | 1,599 | +65 | +4.2% | 1,264,700 |
2018/05/11 | 1,547 | 1,564 | 1,506 | 1,534 | -42 | -2.7% | 682,200 |
2018/05/10 | 1,555 | 1,594 | 1,554 | 1,576 | +19 | +1.2% | 397,500 |
2018/05/09 | 1,566 | 1,576 | 1,533 | 1,557 | -33 | -2.1% | 472,200 |
1551~
1600
件表示中 / 3268件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 46,200円 | +138.6% | - | 0.00% | 42.35倍 | 1.78倍 |
|
ファイザー旧国内研究所が前身。導出した発売済み消化器薬等収益柱に成長、低分子創薬に強い |
ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.54倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
ペルセウス | 72,300円 | 0.0% | - | 0.00% | - | 6.06倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.36倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
市場注目の銘柄
チャート関連のコラム